top of page

Recent Posts

Archive

Tags

North America Molecular Diagnostics Market Will Grow At The Highest CAGR In Future

North America Molecular Diagnostics Market is expected to reach USD 7.2 billion by 2024. Molecular diagnostics is a branch of clinical pathology or laboratory medicine that uses techniques of molecular biology to diagnose disease, monitor the effectiveness of therapies, predict diseases course, and select therapy. North America molecular diagnostics industry is estimated to grow at a significant CAGR in the upcoming period as the scope and its applications are increasing enormously.

The factors that are playing a major role in the growth of North American molecular diagnostics market area technological enhancement in molecular diagnostic kits and rising R&D activities by manufacturers. North America molecular diagnostics market is segmented based on product type, rest location, technology, application, and region.

Reagents, instruments, and the other product types could be explored in North American molecular diagnostics in the forecast period. Reagents sector accounted for the significant market share of North America molecular diagnostics and is estimated to continue with its dominance in the years to come. The reason could be increasing use of these tests in a nonmedical sector like home and molecular diagnostic sector.

Central laboratories, point-of-care, self-test, and others could be explored in North America molecular diagnostics in the forecast period. Central laboratories sector accounted for the significant market share of North America molecular diagnostics. The reason behind the overall market growth could be the presence of ancillary support. In addition, the point-of-care sector is estimated to grow at the highest CAGR in the years to come.

Based on technology, transcription mediated amplification, polymerase chain reaction (PCR), sequencing, in situ hybridization, mass spectrometry, isothermal nucleic acid amplification technology (INAAT), chips and microarrays, and others could classify North America molecular diagnostics in the forecast period. The polymerase chain reaction (PCR) sector accounted for the significant market share of North America molecular diagnostics and is estimated to lead the overall market in the years to come. The reason could be high demand in molecular diagnostics.

The market could be categorized based on applications like microbiology, oncology, cardiovascular disease, pharmacogenomics, neurological disease, infectious disease, genetic testing, and others could be explored in the forecast period. Oncology sector accounted for the substantial market share of North America molecular diagnostics and is estimated to continue its dominance in the years to come. The reason could be the rising occurrence of cancer and increasing enhanced diagnostic tests. The sector is also estimated to grow at the highest CAGR in the years to come.

The United States accounted for the substantial market share of North America molecular diagnostics and is estimated to lead the overall market in the years to come. The reason behind the overall market growth could be the presence of key manufacturers in this region and raised awareness of personalized medicines. Canada is estimated to follow the suit. The key players of North America molecular diagnostics market are QIAGEN, Abbott Laboratories, Dako, Roche Diagnostics, Danaher Corporation, Hologic, Inc., Dickinson and Company (BD), Novartis AG, BioMérieux SA, Bio-Rad Laboratories, Inc., Siemens Healthineers GmbH, Alere, Sysmex Corporation, and Johnson & Johnson Services, Inc. These players are concentrating on inorganic growth to sustain themselves amidst fierce competition.

Market Segment:

North America Molecular Diagnostics Product Outlook (Market Revenue in USD Million, 2013 - 2024) • Instruments • Reagents • Others

North America Molecular Diagnostics Test Location Outlook (Market Revenue in USD Million, 2013 - 2024) • Point of care • Self-testing or OTC • Central laboratories

North America Molecular Diagnostics Technology Outlook (Market Revenue in USD Million, 2013 - 2024) • PCR • In-situ hybridization • Isothermal Nucleic Acid Amplification Technology (INAAT) • Chips and microarrays • Mass spectrometry • Sequencing • Transcription-mediated amplification • Others

North America Molecular Diagnostics PCR, by segments Outlook (Market Revenue in USD Million, 2013 - 2024) • Multiplex PCR • Others

North America Molecular Diagnostics Application Outlook (Market Revenue in USD Million, 2013 - 2024) • Oncology • Pharmacogenomics • Infectious diseases • Genetic testing • Neurological diseases • Cardiovascular diseases • Microbiology • Others

The report “North America Molecular Diagnostics Market” is available now at https://www.millioninsights.com/industry-reports/north-america-molecular-diagnostics-market

North America Molecular Diagnostics Oncology, by Application Outlook (Market Revenue in USD Million, 2013 - 2024) • Breast Cancer • Prostate Cancer • Colorectal Cancer • Cervical Cancer • Kidney Cancer • Liver Cancer • Blood Cancer • Lung Cancer • Others

North America Molecular Diagnostics Infectious Disease, by Application Outlook (Market Revenue in USD Million, 2013 - 2024) • Methicillin-resistant Staphylococcus aureus (MRSA) • Clostridium difficile • Vancomycin-resistant enterococci • Carbapenem-resistant bacteria testing • Flu • Respiratory syncytial virus (RSV) • Candida • Tuberculosis (TB) and drug-resistant TB • Meningitis • Gastrointestinal panel testing • Chlamydia • Gonorrhea • HIV • Hepatitis C • Hepatitis B • Others

North America Molecular Diagnostics Genetic Testing, by Application Outlook (Market Revenue in USD Million, 2013 - 2024) • Newborn screening • Predictive and presymptomatic testing • Others

North America Molecular Diagnostics Country Outlook (Market Revenue in USD Million, 2013 - 2024) • U.S. • Canada

Comments

bottom of page